Review



background sniper bsa  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc background sniper bsa
    Immunohistochemistry details.
    Background Sniper Bsa, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc07240743-23-9-14?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 11 article reviews
    background sniper bsa - by Bioz Stars, 2026-07
    93/100 stars

    Images

    1) Product Images from "Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer"

    Article Title: Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

    Journal: Life Science Alliance

    doi: 10.26508/lsa.201900562

    Immunohistochemistry details.
    Figure Legend Snippet: Immunohistochemistry details.

    Techniques Used: Immunohistochemistry, Blocking Assay



    Similar Products

    background sniper with 1% bsa 20% donkey serum, and 20% goat serum  (Biocare Medical)
    90
    Biocare Medical background sniper with 1% bsa 20% donkey serum, and 20% goat serum
    Background Sniper With 1% Bsa 20% Donkey Serum, And 20% Goat Serum, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc11721158-100-36-30?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    background sniper with 1% bsa 20% donkey serum, and 20% goat serum - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    background sniper + 2% bsa  (Biocare Medical)
    90
    Biocare Medical background sniper + 2% bsa
    Background Sniper + 2% Bsa, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc11721158-108-14-8?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    background sniper + 2% bsa - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    background sniper 2% bsa  (Biocare Medical)
    90
    Biocare Medical background sniper 2% bsa
    Background Sniper 2% Bsa, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc10183362-71-18-24?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    background sniper 2% bsa - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    background sniper bsa  (Cell Signaling Technology Inc)
    93
    Cell Signaling Technology Inc background sniper bsa
    Immunohistochemistry details.
    Background Sniper Bsa, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc07240743-23-9-14?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    background sniper bsa - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    background sniper with 1.0% bovine serum albumin/bsa for cd34  (Biocare Medical)
    90
    Biocare Medical background sniper with 1.0% bovine serum albumin/bsa for cd34
    Examples of slides stained using immunohistochemistry, and scanned at ×20 objective (×200 final magnification), immunohistochemical expression of: (A) <t>CD34</t> in tumor; (B) PSMA in tumor; (C) CD34 in tumor thrombus; (D) PSMA in tumor thrombus. While CD34 shows a somewhat constant staining intensity, there is an increase in PSMA expression in tumor thrombi when compared with tumor tissue. PSMA, prostate specific membrane antigen.
    Background Sniper With 1.0% Bovine Serum Albumin/Bsa For Cd34, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/background+sniper+bsa/pmc06559938-116-10-0?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    background sniper with 1.0% bovine serum albumin/bsa for cd34 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Immunohistochemistry details.

    Journal: Life Science Alliance

    Article Title: Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer

    doi: 10.26508/lsa.201900562

    Figure Lengend Snippet: Immunohistochemistry details.

    Article Snippet: β5i (PSMB8) , Citrate buffer 100°C 20 min , Background sniper BSA 1% , Cell Signaling #13726 Mouse IgG1, IA5 , 1:400 1.5 h, RT , Tumor.

    Techniques: Immunohistochemistry, Blocking Assay

    Examples of slides stained using immunohistochemistry, and scanned at ×20 objective (×200 final magnification), immunohistochemical expression of: (A) CD34 in tumor; (B) PSMA in tumor; (C) CD34 in tumor thrombus; (D) PSMA in tumor thrombus. While CD34 shows a somewhat constant staining intensity, there is an increase in PSMA expression in tumor thrombi when compared with tumor tissue. PSMA, prostate specific membrane antigen.

    Journal: Translational Andrology and Urology

    Article Title: Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis

    doi: 10.21037/tau.2019.04.10

    Figure Lengend Snippet: Examples of slides stained using immunohistochemistry, and scanned at ×20 objective (×200 final magnification), immunohistochemical expression of: (A) CD34 in tumor; (B) PSMA in tumor; (C) CD34 in tumor thrombus; (D) PSMA in tumor thrombus. While CD34 shows a somewhat constant staining intensity, there is an increase in PSMA expression in tumor thrombi when compared with tumor tissue. PSMA, prostate specific membrane antigen.

    Article Snippet: Biocare Medical Background Sniper with 1.0% bovine serum albumin/BSA for CD34 and 2.0% BSA for PSMA was used for 20 minutes to block non-specific antibody binding.

    Techniques: Staining, Immunohistochemistry, Immunohistochemical staining, Expressing, Membrane

    Comparative digital analysis, PSMA/CD34 positive pixel ratio of 10 paired high powered microscopy fields, showing higher ratio in tumor thrombus (0.74) compared to tumor (0.47), with a 57% increase in relative expression of PSMA (P<0.01). T, tumor; TT, tumor thrombus; PSMA, prostate specific membrane antigen.

    Journal: Translational Andrology and Urology

    Article Title: Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis

    doi: 10.21037/tau.2019.04.10

    Figure Lengend Snippet: Comparative digital analysis, PSMA/CD34 positive pixel ratio of 10 paired high powered microscopy fields, showing higher ratio in tumor thrombus (0.74) compared to tumor (0.47), with a 57% increase in relative expression of PSMA (P<0.01). T, tumor; TT, tumor thrombus; PSMA, prostate specific membrane antigen.

    Article Snippet: Biocare Medical Background Sniper with 1.0% bovine serum albumin/BSA for CD34 and 2.0% BSA for PSMA was used for 20 minutes to block non-specific antibody binding.

    Techniques: Microscopy, Expressing, Membrane

    Comparative digital analysis, PSMA/CD34 positive pixel ratio evaluation of whole histological sections, showing increased ratio in tumor thrombus (0.64) compared to tumor tissue (0.40) with a 60% increase in relative expression of PSMA (P<0.01). T, tumor; TT, tumor thrombus; PSMA, prostate specific membrane antigen.

    Journal: Translational Andrology and Urology

    Article Title: Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis

    doi: 10.21037/tau.2019.04.10

    Figure Lengend Snippet: Comparative digital analysis, PSMA/CD34 positive pixel ratio evaluation of whole histological sections, showing increased ratio in tumor thrombus (0.64) compared to tumor tissue (0.40) with a 60% increase in relative expression of PSMA (P<0.01). T, tumor; TT, tumor thrombus; PSMA, prostate specific membrane antigen.

    Article Snippet: Biocare Medical Background Sniper with 1.0% bovine serum albumin/BSA for CD34 and 2.0% BSA for PSMA was used for 20 minutes to block non-specific antibody binding.

    Techniques: Expressing, Membrane

    Morphological and positive pixel analysis, using three methods of analysis

    Journal: Translational Andrology and Urology

    Article Title: Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis

    doi: 10.21037/tau.2019.04.10

    Figure Lengend Snippet: Morphological and positive pixel analysis, using three methods of analysis

    Article Snippet: Biocare Medical Background Sniper with 1.0% bovine serum albumin/BSA for CD34 and 2.0% BSA for PSMA was used for 20 minutes to block non-specific antibody binding.

    Techniques:

    Histological section of the tumor thrombus, superior ramification (A,B,C,D,E) and inferior ramification (F,G,H,I,J): (A) viable tumor, with strong and diffuse expression of CD34 (B and C) and PSMA (D and E); (F) Bland thrombus, with no viable neoplastic cells, showing moderate staining for CD34 (G and H) and no staining for PSMA, even in CD34 positive vessels (I and J). (A,B,C,D,E,F,G,H,I,J) scanned at ×20 objective and presented at ×100 magnification. (A and F) Hematoxylin and eosin staining. (B,C,D,E) and (G,H,I,J), immunohistochemical staining, with antibodies as indicated. PSMA, prostate specific membrane antigen.

    Journal: Translational Andrology and Urology

    Article Title: Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis

    doi: 10.21037/tau.2019.04.10

    Figure Lengend Snippet: Histological section of the tumor thrombus, superior ramification (A,B,C,D,E) and inferior ramification (F,G,H,I,J): (A) viable tumor, with strong and diffuse expression of CD34 (B and C) and PSMA (D and E); (F) Bland thrombus, with no viable neoplastic cells, showing moderate staining for CD34 (G and H) and no staining for PSMA, even in CD34 positive vessels (I and J). (A,B,C,D,E,F,G,H,I,J) scanned at ×20 objective and presented at ×100 magnification. (A and F) Hematoxylin and eosin staining. (B,C,D,E) and (G,H,I,J), immunohistochemical staining, with antibodies as indicated. PSMA, prostate specific membrane antigen.

    Article Snippet: Biocare Medical Background Sniper with 1.0% bovine serum albumin/BSA for CD34 and 2.0% BSA for PSMA was used for 20 minutes to block non-specific antibody binding.

    Techniques: Expressing, Staining, Immunohistochemical staining, Membrane